Stimulation of hepatocyte growth factor production by heparin-derived oligosaccharides

Journal of Biochemistry

Volumn 141, Issue 5, 2007, Pages 653-660

  Sakiyama, Ryoichi ^a   Fukuta, Kazuhiro ^a   Matsumoto, Kunio ^a   Furukawa, Masumi ^b   Takahashi, Yoshihiro ^c   Nakamura, Toshikazu ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b SAWAI PHARMACEUTICAL CO LTD   (Japan)

^c Saito Laboratory   (Japan)

Author keywords

Glycosaminoglycan; Heparan sulfate; Heparin; HGF; Oligosaccharide

Indexed keywords

DALTEPARIN; DISACCHARIDE; HEPARIN; HEPARIN DERIVATIVE; HEPARIN FRAGMENT; HEPARIN LYASE; OLIGOSACCHARIDE; SCATTER FACTOR;

ANION EXCHANGE CHROMATOGRAPHY; ANTICOAGULATION; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG ACTIVITY; FIBROBLAST CULTURE; FRACTIONATION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; STIMULATION; SULFATION;

ANIMALS; ANTICOAGULANTS; CELLS, CULTURED; CHROMATOGRAPHY, ION EXCHANGE; CULTURE MEDIA, CONDITIONED; HEPARIN; HEPATOCYTE GROWTH FACTOR; HUMANS; OLIGOSACCHARIDES; SUS SCROFA;

EID: 34347349205     PISSN: 0021924X     EISSN: None     Source Type: Journal    
DOI: 10.1093/jb/mvm067     Document Type: Article

References (39)

1. Casu, B. (1985) Structure and biological activity of heparin. Adv. Carbohydr. Chem. Biochem. 43, 51-134
2. Bourin, M.C and Lindahl, U. (1993) Glycosaminoglycans and the regulation of blood coagulation. Biochem. J. 289, 313-330
3. Olivecrona, T., Bengtsson-Olivecrona, G., Ostergaard, P., Liu, G., Chevreuil, O., and Hultin, M. (1993) New aspects on heparin and lipoprotein metabolism. Haemostasis 23 (Suppl 1)150-160
4. Sharath, M.D., Merchant, Z.M., Kim, Y.S., Rice, K.G., Linhardt, R.J., and Weiler, J.M. (1985) Small heparin fragments regulate the amplification pathway of complement. Immunopharmacology 9, 73-80
5. Folkman, J. and Shing, Y. (1992) Control of angiogenesis by heparin and other sulfated polysaccharides. Adv. Exp. Med. Biol. 313, 355-364
6. Khorana, A.A., Sahni, A., Altland, O.D., and Francis, C.W. (2003) Heparin inhibition of endothelial cell proliferation and organization is dependent on molecular weight. Arterioscler. Thromb. Vasc. Biol. 23, 2110-2115
7. Holodniy, M., Kim, S., Katzenstein, D., Konrad, M., Groves, E., and Merigan, T.C. (1991) Inhibition of human immunodeficiency virus gene amplification by heparin. J. Clin. Microbiol. 29, 676-679
8. Elsayed, E. and Becker, R.C. (2003) The impact of heparin compounds on cellular inflammatory responses: a construct for future investigation and pharmaceutical development. J. Thromb. Thrombolysis 15, 11-18
9. Jackson, R.L., Busch, S.J., and Cardin, A.D. (1991) Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes. Physiol. Rev. 71, 481-539
10. Matsumoto, K., Tajima, H., Okazaki, H., and Nakamura, T. (1993) Heparin as an inducer of hepatocyte growth factor. J. Biochem. (Tokyo) 114, 820-826
11. Nakamura, T., Nawa, K., and Ichihara, A. (1984) Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem. Biophys. Res. Commun. 122, 1450-1459
12. Nakamura, T., Nishizawa, T., Hagiya, M., Seki, T., Shimonishi, M., Sugimura, A., Tashiro, K., and Shimizu, S. (1989) Molecular cloning and expression of human hepatocyte growth factor. Nature 342, 440-443
13. Miyazawa, K., Tsubouchi, H., Naka, D., Takahashi, K., Okigaki, M., Arakaki, N., Nakayama, H., Hirono, S., Sakiyama, O., Takahashi, K., Gohda, E., Daikuhara, Y., and Kitamura, N. (1989) Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem. Biophys. Res. Commun. 163, 967-973
14. Matsumoto, K. and Nakamura, T. (1997) Hepatocyte growth factor (HGF) as a tissue organizer for organogenesis and regeneration. Biochem. Biophys. Res. Commun. 239, 639-644
15. Birchmeier, C. and Gherardi, E. (1998) Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase. Trends. Cell Biol. 8, 404-410
16. Holmer, E., Kurachi, K., and Soderstrom, G. (1981) The molecular-weight dependence of the rate-enhancing effect of heparin on the inhibition of thrombin, factor Xa, factor IXa, factor XIa, factor XIIa and kallikrein by antithrombin. Biochem. J. 193, 395-400
17. Holmer, E., Soderberg, K., Bergqvist, D., and Lindahl, U. (1986) Heparin and its low molecular weight derivatives: anticoagulant and antithrombotic properties. Haemostasis 16(Suppl. 2), 1-7
18. Bitter, T. and Muir, H.M. (1962) A modified uronic acid carbazole reaction. Anal. Biochem. 4, 330-334
19. Matsumoto, K., Tajima, H., Hamanoue, M., Kohno, S., Kinoshita, T., and Nakamura, T. (1992) Identification and characterization of "injurin," an inducer of expression of the gene for hepatocyte growth factor. Proc. Natl. Acad. Sci. USA 89, 3800-3804
20. Teien, A.N., Lie, M., and Abildgaard, U. (1976) Assay of heparin in plasma using a chromogenic substrate for activated factor X. Thromb. Res. 8, 413-416
21. Larsen, M.L., Abildgaard, U., Teien, A.N., and Gjesdal, K. (1978) Assay of plasma heparin using thrombin and the chromogenic substrate H-D-Phe-Pip-Arg-pNA (S-2238). Thromb. Res. 13, 285-288
22. Juhasz, P. and Biemann, K. (1995) Utility of non-covalent complexes in the matrix-assisted laser desorption ionization mass spectrometry of heparin-derived oligosaccharides. Carbohydr. Res. 270, 131-147
23. Shriver, Z., Raman, R., Venkataraman, G., Drummond, K., Turnbull, J., Toida, T., Linhardt, R., Biemann, K., and Sasisekharan, R. (2000) Sequencing of 3-O sulfate containing heparin decasaccharides with a partial antithrombin III binding site. Proc. Natl. Acad. Sci. USA 97, 10359-10364
24. Desai, U.R., Petitou, M., Bjork, I., and Olson, S.T. (1998) Mechanism of heparin activation of antithrombin. Role of individual residues of the pentasaccharide activating sequence in the recognition of native and activated states of antithrombin. J. Biol. Chem. 273, 7478-7487
25. Thunberg, L., Backstrom, G., and Lindahl, U. (1982) Further characterization of the antithrombin-binding sequence in heparin. Carbohydr. Res. 100, 393-410
26. Choay, J., Petitou, M., Lormeau, J.C., Sinay, P., Casu, B., and Gatti, G. (1983) Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity. Biochem. Biophys. Res. Commun. 116, 492-499
27. Lyon, M., Deakin, J.A., Mizuno, K., Nakamura, T., and Gallagher, J.T. (1994) Interaction of hepatocyte growth factor with heparan sulfate. Elucidation of the major heparan sulfate structural determinants. J. Biol. Chem. 269, 11216-11223
28. Ashikari, S., Habuchi, H., and Kimata, K. (1995) Characterization of heparan sulfate oligosaccharides that bind to hepatocyte growth factor. J. Biol. Chem. 270, 29586-29593
29. Ashikari-Hada, S., Habuchi, H., Kariya, Y., Itoh, N., Reddi, A.H., and Kimata, K. (2004) Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library. J. Biol. Chem. 279, 12346-12354
30. Lyon, M., Deakin, J.A., Lietha, D., Gherardi, E., and Gallagher, J.T. (2004) The interactions of hepatocyte growth factor/scatter factor and its NK1 and NK2 variants with glycosaminoglycans using a modified gel mobility shift assay. Elucidation of the minimal size of binding and activatory oligosaccharides. J. Biol. Chem. 279, 43560-43567
31. Lyon, M., Deakin, J.A., Rahmoune, H., Fernig, D.G., Nakamura, T., and Gallagher, J.T. (1998) Hepatocyte growth factor/scatter factor binds with high affinity to dermatan sulfate. J. Biol. Chem. 273, 271-278
32. Lapierre, F., Holme, K., Lam, L., Tressler, R.J., Storm, N., Wee, J., Stack, R.J., Castellot, J., and Tyrrell, D.J. (1996) Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties. Glycobiology 6, 355-366
33. Sache, E., Maillard, M., Malazzi, P., and Bertrand, H. (1989) Partially N-desulfated heparin as a non-anticoagulant heparin: some physico-chemical and biological properties. Thromb. Res. 55, 247-258
34. Danishefsky, I., Ahrens, M., and Klein, S. (1977) Effect of heparin modification on its activity in enhancing the inhibition of thrombin by antithrombin III. Biochim. Biophys. Acta 498, 215-222
35. Wan, J.G., Mu, J.S., Zhu, H.S., and Geng, J.G. (2002) N-desulfated non-anticoagulant heparin inhibits leukocyte adhesion and transmigration in vitro and attenuates acute peritonitis and ischemia and reperfusion injury in vivo. Inflamm. Res. 51, 435-443
36. Yuan, L., Geng, J.G., and Xu, Q. (2003) N-desulfated heparin improves concanavalin A-induced liver injury partly through inhibiting T lymphocyte adhesion. Inflamm. Res. 52, 383-389
37. Matsumoto, K. and Nakamura, T. (2001) Hepatocyte growth factor: renotropic role and potential therapeutics for renal diseases. Kidney Int. 59, 2023-2038
38. Funakoshi, H. and Nakamura, T. (2003) Hepatocyte growth factor: from diagnosis to clinical applications. Clin. Chim. Acta 327, 1-23
39. Morishita, R., Aoki, M., Hashiya, N., Makino, H., Yamasaki, K., Azuma, J., Sawa, Y., Matsuda, H., Kaneda, Y., and Ogihara, T. (2004) Safety evaluation of clinical gene therapy using hepatocyte growth factor to treat peripheral arterial disease. Hypertension 44, 203-209